GlassScriptPhysician profile
Osman Chaudhry
NPI 1982054136
$10,337.42
in general payments reported to CMS, 2019-2025
29 companies · $5,717 in 2025
The $5,717 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $459 · 2022: $2,576 · 2023: $1,452 · 2024: $133 · 2025: $5,717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,094 · Travel and Lodging: $2,711 · Food and Beverage: $1,496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,094.00 |
| Travel and Lodging | $2,711.16 |
| Food and Beverage | $1,496.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,246.61 | 2024-2025 | |
| Acessa Health INC. | $1,745.69 | 2022 | |
| Hologic Sales and Service, LLC | $867.02 | 2022-2023 | Acessa Provu System |
| Astellas Pharma US INC | $554.37 | 2022-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $340.75 | 2022-2023 | Lo Loestrin Fe, Orilissa |
| Medical Device Business Services, INC. | $325.00 | 2021 | |
| Sumitomo Pharma America, INC. | $123.58 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $120.85 | 2022-2025 | |
| Agile Therapeutics, INC. | $105.16 | 2022-2023 | Twirla |
| Organon LLC | $85.88 | 2022-2023 | Nexplanon |
| Myovant Sciences INC. | $73.31 | 2021-2022 | |
| Evofem Biosciences, INC. | $72.69 | 2021-2023 | Phexxi |
| Mayne Pharma Commercial LLC | $65.76 | 2021-2025 | |
| Ethicon US, LLC | $63.51 | 2021-2022 | |
| Exeltis, USA INC. | $62.76 | 2023-2025 | Slynd |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $59.78 | 2021-2023 | |
| Millicent US INC | $51.01 | 2025 | Femlyv, Intrarosa |
| Exact Sciences Corporation | $50.39 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Baxter Healthcare | $47.29 | 2023 | Perclot |
| Biogen, INC. | $44.81 | 2025 | Zurzuvae |
| Amgen INC. | $38.00 | 2021-2022 | |
| Coopersurgical, INC. | $36.03 | 2024-2025 | Paragard T 380a |
| Sage Therapeutics, LLC | $32.99 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $30.00 | 2022-2023 | Caldolor |
| Minerva Surgical, INC | $22.94 | 2023 | |
| Mylan Pharmaceuticals INC. | $21.30 | 2022 | |
| Innovation Technologies INC | $19.85 | 2025 | Irrisept |
| Avion Pharmaceuticals | $17.72 | 2023 | Balcoltra |
| Therapeuticsmd, INC. | $12.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Osman Chaudhry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.